MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Lung Cancer Treatments and Mutations
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,464 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,464 works in the cohort · of 4,299,418page 15 of 50

Labels cover 16 of 2,464 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,464 of 2,464 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
<i>ROS1-1</i>
Prodipto Pal, Zanobia Khan
2017· review· en· Journal of Clinical Pathology· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affunlabeled
Updated molecular analyses of exons 19 and 21 of the epidermal growth factor receptor (<i>EGFR</i>) gene and codons 12 and 13 of the <i>KRAS</i> gene in non-small cell lung cancer (NSCLC) patients treated with erlotinib in National Cancer Institute of Cancer
Frances A. Shepherd, Keyue Ding, Akira Sakurada, Gilda da Cunha Santos, Chang‐Qi Zhu, Lesley Seymour +4 more
2007· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
afffundunlabeled
Human Lung Tissue Transcriptome: Influence of Sex and Age
Matteo Dugo, Chiara E. Cotroneo, Émilie Lavoie-Charland, Matteo Incarbone, L. Santambrogio, Lorenzo Rosso +6 more
2016· article· en· PLoS ONE· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
affunlabeled
IND.175: Phase I study of daily oral AZD2171, a vascular endothelial growth factor receptor inhibitor (VEGFRI), in combination with gemcitabine and cisplatin (G/C) in patients with advanced non-small cell lung cancer (ANSCLC): A study of the NCIC Clinical Trials Group
Glenwood Goss, Scott A. Laurie, Frances A. Shepherd, Natasha B. Leighl, E. Chen, Isabelle Gauthier +4 more
2007· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
afffundunlabeled
An ErbB2 splice variant lacking exon 16 drives lung carcinoma
Harvey W. Smith, Lei Yang, Ling Chen, Arlan Walsh, Victor D. Martínez, Jonathan Boucher +9 more
2020· article· en· Proceedings of the National Academy of Sciences· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
← previousnext →

How this was built: Screen · Findings · About